» Articles » PMID: 19764761

Identification of the ADP-ribosylation Sites in the PARP-1 Automodification Domain: Analysis and Implications

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2009 Sep 22
PMID 19764761
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) is a multimodular (domains A, B, C, D, E, and F) nuclear protein that participates in many fundamental cellular activities. Stimulated by binding to nicked DNA, PARP-1 catalyzes poly(ADP-ribosyl)ation of the acceptor proteins and itself using NAD(+) as a substrate. Early studies suggested that domain D is likely an interface for protein-protein interaction between PARP-1 and its targets and is also the primary region for automodification. However, determination of the modification sites has been complicated by the heterogeneous nature of the poly(ADP-ribose) polymer. Here we report a strategy to identify the modification sites on domain D using the PARP-1 E988Q mutant, which only catalyzes mono(ADP-ribosyl)ation. Trypsin digestion of the modified domain D followed by LC-MS/MS analysis led to the identification of three ADP-ribosylation sites in domain D (D387, E488, and E491). Our data also show, in contrast to early reports, that automodification of PARP-1 is not limited to domain D but occurs beyond this region. In addition, domain D is not essential for PARP-1 activity since PARP-1 mutant having domain D deleted is still catalytically active. Two synthetic peptides with amino acid sequences derived from the ADP-ribosylation sites of domain D were also demonstrated to act as PARP-1 substrates. The methodology and the results reported herein will facilitate future studies of PARP-1 catalysis.

Citing Articles

Single-molecule analysis of PARP1-G-quadruplex interaction.

Gaur P, Bain F, Meah R, Spies M bioRxiv. 2025; .

PMID: 39829912 PMC: 11741300. DOI: 10.1101/2025.01.06.631587.


Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection.

Zhang Z, Uribe I, Davis K, McPherson R, Larson G, Badiee M bioRxiv. 2024; .

PMID: 39345583 PMC: 11430048. DOI: 10.1101/2024.09.19.613696.


PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells.

Huang M, Zhu X, Wang C, He L, Li L, Wang H Cell Death Dis. 2024; 15(8):610.

PMID: 39174499 PMC: 11341912. DOI: 10.1038/s41419-024-07009-6.


Preserving ester-linked modifications reveals glutamate and aspartate mono-ADP-ribosylation by PARP1 and its reversal by PARG.

Longarini E, Matic I Nat Commun. 2024; 15(1):4239.

PMID: 38762517 PMC: 11102441. DOI: 10.1038/s41467-024-48314-0.


Deregulated DNA ADP-ribosylation impairs telomere replication.

Wondisford A, Lee J, Lu R, Schuller M, Groslambert J, Bhargava R Nat Struct Mol Biol. 2024; 31(5):791-800.

PMID: 38714889 PMC: 11102865. DOI: 10.1038/s41594-024-01279-6.